These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Open-label pilot study of extended-release naltrexone to reduce drinking and driving among repeat offenders. Lapham SC; McMillan GP J Addict Med; 2011 Sep; 5(3):163-9. PubMed ID: 21844831 [TBL] [Abstract][Full Text] [Related]
6. Extended-release naltrexone plus medical management alcohol treatment in primary care: findings at 15 months. Lee JD; Grossman E; Huben L; Manseau M; McNeely J; Rotrosen J; Stevens D; Gourevitch MN J Subst Abuse Treat; 2012 Dec; 43(4):458-62. PubMed ID: 22985676 [TBL] [Abstract][Full Text] [Related]
8. Early treatment response in alcohol dependence with extended-release naltrexone. Ciraulo DA; Dong Q; Silverman BL; Gastfriend DR; Pettinati HM J Clin Psychiatry; 2008 Feb; 69(2):190-5. PubMed ID: 18348601 [TBL] [Abstract][Full Text] [Related]
9. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study. Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401 [TBL] [Abstract][Full Text] [Related]
11. Long-acting injectable naltrexone for the treatment of alcohol dependence. Mannelli P; Peindl K; Masand PS; Patkar AA Expert Rev Neurother; 2007 Oct; 7(10):1265-77. PubMed ID: 17939765 [TBL] [Abstract][Full Text] [Related]
12. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818 [TBL] [Abstract][Full Text] [Related]
13. Preliminary evaluation of extended-release naltrexone in Michigan and Missouri drug courts. Finigan MW; Perkins T; Zold-Kilbourn P; Parks J; Stringer M J Subst Abuse Treat; 2011 Oct; 41(3):288-93. PubMed ID: 21696912 [TBL] [Abstract][Full Text] [Related]
16. Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care (XON). Malone M; McDonald R; Vittitow A; Chen J; Obi R; Schatz D; Tofighi B; Garment A; Kermack A; Goldfeld K; Gold H; Laska E; Rotrosen J; Lee JD Contemp Clin Trials; 2019 Jun; 81():102-109. PubMed ID: 30986535 [TBL] [Abstract][Full Text] [Related]
17. Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients. Pettinati HM; Gastfriend DR; Dong Q; Kranzler HR; O'Malley SS Alcohol Clin Exp Res; 2009 Feb; 33(2):350-6. PubMed ID: 19053979 [TBL] [Abstract][Full Text] [Related]
18. Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking. Hernandez-Avila CA; Song C; Kuo L; Tennen H; Armeli S; Kranzler HR Alcohol Clin Exp Res; 2006 May; 30(5):860-5. PubMed ID: 16634855 [TBL] [Abstract][Full Text] [Related]
19. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes. Monti PM; Rohsenow DJ; Swift RM; Gulliver SB; Colby SM; Mueller TI; Brown RA; Gordon A; Abrams DB; Niaura RS; Asher MK Alcohol Clin Exp Res; 2001 Nov; 25(11):1634-47. PubMed ID: 11707638 [TBL] [Abstract][Full Text] [Related]
20. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial. O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]